Magjun Shala

Magjun Shala

Auto-generated profile, based on publicly available information

Magjun Shala

Faculty of Medicine and Biology, Lausanne University, Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2020 in Journal of Cardiovascular and Thoracic Research
Verified
Journal Article
Open access
PDF file
MSMagjun Shala
Magjun Shala
LNLars Niclauss
Lars Niclauss
The Inspiris Resilia aortic valve® (INSPIRIS) is a pericardial bio-prosthesis with a new sterilization procedure that shows promising results in terms of reduced calcification. The 30-day mortality and morbidity were analyzed, comparing the INSPIRIS implanted between May 2017 and the end of January 2019, with its "predecessor", the Carpentier-Edwards Perimound Magna Ease (ME). Echocardiography was performed one-week after surgery. 125 consecutively operated patients were included (59 INSPIRIS, 66 ME). One patient in the ME group died and one patient in the INSPIRIS group had a complicated postoperative course due to right heart failure. Two patients (one INSPIRIS, one ME patient) suffered a perioperative stroke. The hemodynamic evaluation shows an effective reduction of mean transvalvular pressure gradients after surgery in both groups. INSPIRIS tended to have lower trans-prosthetic pressure gradients (9 mm Hg, Interquartile range [IQR] 11-7 mm Hg versus 12 mm Hg, IQR 15-9 mm Hg; P=0.001), reduced trans-prosthetic blood flow acceleration (209 cm/s, IQR 220-190 cm/s versus 227 cm/s, IQR 263-191 cm/s; P=0.003) and increased permeability indices (57%, IQR 67%-47% versus 42%, IQR 48%-38%; P<0.001). There are only few clinical data available from INSPIRIS, and the present analysis confirms good results initial postoperatively with a tendency towards possibly improved hemodynamics compared to ME.